Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

Autoantibodies to adenozine deaminase as marker of immunological disorders in systemic lupus erythematosus

Show simple item record

dc.contributor.author Alexandrova, N.V.
dc.contributor.author Alekhina, I.Y.
dc.contributor.author Alexandrov, A.V.
dc.contributor.author Zborovskaja, I.A.
dc.date.accessioned 2021-03-02T08:23:06Z
dc.date.available 2021-03-02T08:23:06Z
dc.date.issued 2011
dc.identifier.citation ALEXANDROVA, N.V., ALEKHINA, I.Y., ALEXANDROV, A.V., ZBOROVSKAJA, I.A. Autoantibodies to adenozine deaminase as marker of immunological disorders in systemic lupus erythematosus. In: Sănătate Publică, Economie şi Management în Medicină. 2011, nr. 2(2), pp. 59-60. ISSN 1729-8687. en_US
dc.identifier.issn 1729-8687
dc.identifier.uri http://revistaspemm.md/wp-content/uploads/2019/05/cm2_2_2011.pdf
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/15988
dc.description Conferinţa naţională în medicina internă din Republica Moldova cu participare internaţională, 19-20 mai 2011, Chişinău, Republica Moldova en_US
dc.description.abstract Objectives. The autoantibodies to various enzymes are often found out in sera of systemic lupus erythematosus (SLE) patients, but clinical value of such antibodies often is not understood. Purpose. The purpose of work was to study the of antibodies generation to the basic enzyme of purine metabolism – Adenozine Deaminase (ADA) in SLE and to reveal the relationship of studied antibodies with clinical and laboratory features of pathological process. Methods. 30 healthy persons have been included in our study and 71 SLE patients (66 women and 5 men) with various clinical signs (44 persons had 1st degree of disease activity, 27 persons – 2nd degree of pathological process activity). 18 women had habitual noncarrying of pregnancy (HNP) in anamnesis. Antibodies of IgG class to ADA (anti- ADA) determined by technique of indirect ELISA developed by us with the use of immobilized form of ADA as an antigenic matrix. β2-glicoprotein-I-dependent antiphospholipids (aPhL) of IgG and IgМ classes were determined using commercial „Anti- Phospholipid Screen IgG/IgM” test set (Orgentec Diagnostica). Results. At admission an anti-ADA was revealed in 36,6%, aPhL of IgG class – in 45,1%, and aPhL of IgМ class – in 23 (32,4%) SLE patients. It has been noted that IgG- aPhL were found out in anti-ADA-positive patients more often and in higher antibody titer, than in anti-ADA-negative SLE patients (χ2 =6,4; р <0,02). Development of cytopenic syndrome was noted reliable more often in SLE patients with associated presence of IgGaPhL and an anti-ADA in comparison with patients who has not the combinations of these antibodies in blood (χ2 = 3,9; р <0,05). The increased levels of anti-ADA were revealed in 11 of 18 women with HNP, and the combination of anti-ADA and aPhL (9/18) was found out more often than isolated anti-ADA (2/18, χ2 =6,5; р <0,02) or isolated aPhL (3/18, χ2 =4,5; р <0,05). Conclusion. Taking into account the imbalance of immunoregulatory functions in SLE, the further studying of autoantibodies to ADA generation seems to be very promising. Presence of HNP in anamnesis is the evidence of necessity of careful biochemical monitoring of aPhL and anti-ADA in women for the prevention of abortus fetus and administration of adequate therapy. en_US
dc.language.iso en en_US
dc.publisher Asociația Obștească ”Economie, Management și Psihologie în Medicină” din Republica Moldova en_US
dc.relation.ispartof Sănătate Publică, Economie și Management în Medicină: Conferinţa naţională în medicina internă din Republica Moldova cu participare internaţională, 19-20 mai 2011, Chişinău, Republica Moldova en_US
dc.title Autoantibodies to adenozine deaminase as marker of immunological disorders in systemic lupus erythematosus en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics